Table of Contents
ISRN Pharmaceutics
Volume 2013 (2013), Article ID 674507, 8 pages
http://dx.doi.org/10.1155/2013/674507
Research Article

Formulation Development and Evaluation of Fast Disintegrating Tablets of Salbutamol Sulphate for Respiratory Disorders

CT Institute of Pharmaceutical Sciences, Shahpur, PO Udopur, Near Lambra, Jalandhar, Punjab 144020, India

Received 23 May 2013; Accepted 20 June 2013

Academic Editors: R. Zelkó and A. S. Zidan

Copyright © 2013 Deepak Sharma. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Pahwa, M. Piplani, P. C. Sharma, D. Kaushik, and S. Nanda, “Orally disintegrating tablets—friendly to pediatrics and geriatrics,” Archives of Applied Science Research, vol. 2, no. 2, pp. 35–48, 2010. View at Google Scholar
  2. S. Divate, K. Kavitha, and G. N. Sockan, “Fast disintegrating tablets—an emerging trend,” International Journal of Pharmaceutical Sciences Review and Research, vol. 6, no. 2, pp. 18–22, 2011. View at Google Scholar · View at Scopus
  3. R. Panigrahi and S. A. Behera, “Review on fast dissolving tablets,” Webmed Central Quality and Patient, vol. 1, no. 9, pp. 1–17, 2010. View at Google Scholar
  4. M. Slowson and S. Slowson, “What to do when patients cannot swallow their medications,” Pharma Times, vol. 51, pp. 90–96, 1985. View at Google Scholar
  5. S. Corveleyn and J. P. Remon, “Formulation and production of rapidly disintegrating tablets by lyophilisation using hydrochlorothiazide as a model drug,” International Journal of Pharmaceutics, vol. 152, no. 2, pp. 215–225, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. A. K. Nayak and K. Manna, “Current developments in orally disintegrating tablet technology,” Journal of Pharmaceutical Education and Research, vol. 2, no. 1, pp. 21–34, 2011. View at Google Scholar
  7. S. A. Sreenivas, P. M. Dandagi, A. P. Gadad et al., “Orodispersible tablet: new-fanged drug delivery system—a review,” Indian Journal of Pharmaceutical Education and Research, vol. 39, no. 4, pp. 177–181, 2005. View at Google Scholar
  8. D. Bhowmik, B. Chiranjib, K. Pankaj, and M. R. Chandira, “Fast dissolving tablet: an overview,” Journal of Chemical and Pharmaceutical Research, vol. 1, no. 1, pp. 163–177, 2009. View at Google Scholar
  9. B. G. Prajapati and N. Ratnakar, “A review on recent patents on fast dissolving drug delivery system,” International Journal of PharmTech Research, vol. 1, no. 3, pp. 790–798, 2009. View at Google Scholar · View at Scopus
  10. M. Swamivelmanickam, R. Manavalan, and K. Valliappan, “Mouth dissolving tablets: an overview,” International Journal of Pharmaceutical Sciences and Research, vol. 1, no. 12, pp. 43–55, 2010. View at Google Scholar
  11. K. D. Tripathi, Essential of Medical Pharmacology, pp. 216–217, Jaypee Brothers Medical, New Delhi, India, 6th edition, 2008.
  12. S. B. Jadhav, D. R. Kaudewar, G. S. Kaminwar, A. B. Jadhav, R. V. Kshirsagar, and D. M. Sakarkar, “Formulation and evaluation of dispersible tablets of diltiazem hydrochloride,” International Journal of PharmTech Research, vol. 3, no. 3, pp. 1314–1321, 2011. View at Google Scholar · View at Scopus
  13. V. Metker, A. Kumar, N. Pathak, K. Padhee, and S. Sahoo, “Formulation and evaluation of orodispersible tablets of lornoxicam,” International Journal of Drug Development and Research, vol. 3, no. 1, pp. 281–285, 2011. View at Google Scholar
  14. A. Arya, S. Sharma, J. Kumar, A. Chandra, and P. Jaiswal, “Formulation and evaluation of mouth dissolving tablets of ranitidine HCL,” International Journal of Pharm Tech Research, vol. 2, no. 2, pp. 1574–1577, 2010. View at Google Scholar
  15. R. B. Parmar, A. H. Baria, H. M. Tank, and S. D. Faldu, “Formulation and evaluation of domperidone fast dissolving tablets,” International Journal of PharmTech Research, vol. 1, no. 3, pp. 483–487, 2009. View at Google Scholar · View at Scopus
  16. B. Senthilnathan and A. Rupenagunta, “Formulation development and evaluation of venlafaxine hydrochloride orodispersible tablets,” International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 4, pp. 913–921, 2011. View at Google Scholar
  17. P. B. Anjankumar, M. Nazmuddin, U. Kulkarni, and R. C. Hariprasanna, “Formulation and evaluation of lornoxicam fast dissolving tablet,” International Research Journal of Pharmacy, vol. 2, no. 4, pp. 130–133, 2011. View at Google Scholar
  18. N. C. Mohire and A. V. Yadav, “Novel approach to formulate β-cyclodextrin complexed mouth dissolving tablet of metronidazole and its in-vitro evaluation,” Journal of Pharmacy Research, vol. 3, no. 3, pp. 662–667, 2010. View at Google Scholar
  19. ICH Harmonised Tripartite Guideline. Cover Note for Revision of Q1A(R) Stability Testing of New Drug Substances and Products.Q1A (R2): pp. 9.